Suggested Topics within your search.
Suggested Topics within your search.
2
Fluorescent Antibody Technique
1
Antibodies, Monoclonal
1
Antigen-Antibody Reactions
1
Cellen (biologie)
1
Cerebrospinal Fluid
1
Diagnose
1
Encephalomyelitis, Autoimmune, Experimental
1
Factor VIII
1
Graft Rejection
1
Hemofilie
1
Immunofluorescentie
1
Microscopy, Fluorescence
1
Monoklonale antistoffen
1
Multiple Sclerosis
1
Neuropathologie
1
Nierceltumoren
1
Transplantation, Homologous
1
Virus Diseases
1
Virusziekten
1
cytology
1
diagnosis
1
drug therapy
1
immunology
1
therapeutic use
-
1by Paul, Leendert C.### CRL customization ### ?> ### Add publisher and desc details ### ?>
Published 1979's-Gravenhage, Netherlands : J.H. Pasmans, 1979.140 p. : ill. ; 24 cm.Subjects: “...Antigen-Antibody Reactions....”
-
2by Haaijman, J. J.### CRL customization ### ?> ### Add publisher and desc details ### ?>
Published 1977Rijswijk (Z.H.), The Netherlands : Publication of the Institute for Experimental Gerontology of the Organization for Health Research TNO, 1977.239 p. : ill. ; 25 cm.Subjects: “...Fluorescent Antibody Technique....”
-
3by Clasener, Hendricus Alphonse Lambertus### CRL customization ### ?> ### Add publisher and desc details ### ?>
Published 19321932.69 p.Subjects: “...antibodies....”
-
4by Oosterwijk, Egbert### CRL customization ### ?> ### Add publisher and desc details ### ?>
Published 1987Dordrecht ICG 1987.189 p. -
5by Muller, Hendrik Pieter, 1946-### CRL customization ### ?> ### Add publisher and desc details ### ?>
Published 1981[S.l. : s.n.], 1981.104 p. : ill. ; 24 cm. -
6by Peters, A. C. B. (André Cornelis Boudewijn), 1941-### CRL customization ### ?> ### Add publisher and desc details ### ?>
Published 1979's-Gravenhage, The Netherlands : J.H. Pasmans, 1979.214 p. : ill. ; 24 cm.Subjects: “...Fluorescent Antibody Technique....”
-
7by Lambalgen, R. van (Robert van)### CRL customization ### ?> ### Add publisher and desc details ### ?>
Published 1987Rijswijk, the Netherlands : Primate Center TNO, 1987.140 p. : ill.Subjects: “...Antibodies, Monoclonal therapeutic use....”